2 weeks Ago By ABMN Staff
Canada Pension Plan Investment Board bought a new position in shares of Definitive Healthcare Corp. ( NASDAQ:DH – Free Report ) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 20,000 shares of the company’s stock, valued at approximately $109,000.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Conestoga Capital Advisors LLC lifted its stake in shares of Definitive Healthcare by 1.3% during the 1st quarter.
Conestoga Capital Advisors LLC now owns 5,595,627 shares of the company’s stock worth $45,157,000 after purchasing an additional 74,490 shares during the last quarter. Vanguard Group Inc. raised its holdings in Definitive Healthcare by 1.
5% in the first quarter. Vanguard Group Inc. now owns 4,535,377 shares of the company’s stock worth $36,600,000 after purchasing an additional 67,068 shares in the last quarter.
Massachusetts Financial Services Co. MA boosted its holdings in shares of Definitive Healthcare by 28.3% in the 2nd quarter.
Massachusetts Financial Services Co. MA now owns 4,426,420 shares of the company’s stock valued at $24,168,000 after buying an additional 976,279 shares in the last quarter. Granite Investment Partners LLC grew its position in shares of Definitive Healthcare by 22.
5% in the 2nd quarter. Granite Investment Partners LLC now owns 884,872 shares of the company’s stock worth $4,831,000 after buying an additional 162,432 shares during the last quarter. Finally, Victory Capital Management Inc.
raised its stake in shares of Definitive Healthcare by 1.9% during the 2nd quarter. Victory Capital Management Inc.
now owns 509,009 shares of the company’s stock worth $2,779,000 after acquiring an additional 9,316 shares in the last quarter. Institutional investors own 98.67% of the company’s stock.
Analyst Ratings Changes Several equities analysts have issued reports on the stock. BTIG Research started coverage on shares of Definitive Healthcare in a report on Tuesday, September 17th. They issued a “buy” rating and a $7.
00 price target on the stock. Morgan Stanley reduced their target price on Definitive Healthcare from $9.00 to $5.
00 and set an “equal weight” rating on the stock in a research report on Tuesday, August 6th. Stifel Nicolaus dropped their price target on Definitive Healthcare from $9.50 to $7.
50 and set a “buy” rating on the stock in a research note on Wednesday, July 31st. Robert W. Baird decreased their price objective on shares of Definitive Healthcare from $6.
00 to $5.00 and set a “neutral” rating for the company in a research report on Wednesday, August 7th. Finally, Deutsche Bank Aktiengesellschaft lowered their target price on shares of Definitive Healthcare from $7.
00 to $5.00 and set a “hold” rating for the company in a research note on Friday, August 9th. One analyst has rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the company.
According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $5.81.
Definitive Healthcare Stock Performance DH opened at $4.41 on Friday. The firm has a 50 day moving average of $4.
48 and a two-hundred day moving average of $5.73. The firm has a market capitalization of $520.
09 million, a PE ratio of -2.52, a P/E/G ratio of 6.49 and a beta of 1.
33. The company has a current ratio of 2.40, a quick ratio of 2.
40 and a debt-to-equity ratio of 0.27. Definitive Healthcare Corp.
has a 12-month low of $3.19 and a 12-month high of $10.62.
Definitive Healthcare ( NASDAQ:DH – Get Free Report ) last posted its earnings results on Monday, August 5th. The company reported $0.09 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.
09. The company had revenue of $63.70 million during the quarter, compared to the consensus estimate of $63.
19 million. Definitive Healthcare had a negative net margin of 156.65% and a positive return on equity of 0.
98%. The firm’s quarterly revenue was up 4.4% on a year-over-year basis.
During the same period in the previous year, the firm posted $0.08 earnings per share. On average, analysts anticipate that Definitive Healthcare Corp.
will post 0.07 EPS for the current year. Definitive Healthcare Profile ( Free Report ) Definitive Healthcare Corp.
, together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. Read More Want to see what other hedge funds are holding DH? Visit HoldingsChannel.
com to get the latest 13F filings and insider trades for Definitive Healthcare Corp. ( NASDAQ:DH – Free Report ). Receive News & Ratings for Definitive Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Definitive Healthcare and related companies with MarketBeat.
com's FREE daily email newsletter ..
